FREE TREATMENT REPORT

See ratings and reviews when you sign up for an account.

Auditory and Vestibular Function Evaluation in Patients With Solid Tumors Treated With Oxaliplatin-Containing Chemotherapy

This study is currently Recruiting

July 2011 By Case Comprehensive Cancer Center

First Recieved on March 21, 2006

Last Updated on July 20, 2011

Sponsor: Case Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)
Information provided by: Case Comprehensive Cancer Center
Identifier: NCT00305799

Purpose

RATIONALE: Understanding how oxaliplatin affects hearing loss, dizziness, and peripheral neuropathy may improve the ability to plan effective treatment for patients receiving oxaliplatin for solid tumors. PURPOSE: This clinical trial is studying hearing loss and dizziness in patients receiving oxaliplatin for solid tumors.

Study Type: Observational
Study Design: Observational Model: Cohort, Time Perspective: Prospective

Eligibility

Ages Eligible for Study:18 Years
Genders Eligible for Study:Both
Accepts Healthy Volunteers:No
Criteria

DISEASE CHARACTERISTICS: - Diagnosis of solid tumor - Received an oxaliplatin-containing chemotherapy regimen within the past 15 months* NOTE: *If oxaliplatin was omitted from the patient's most recent chemotherapy regimen due to ototoxicity, the patient is still eligible for participation in this study - No known CNS metastases PATIENT CHARACTERISTICS: - No history of spinal injuries - ECOG performance status 0-3 - No history of chronic renal failure - No known HIV/AIDS PRIOR CONCURRENT THERAPY: - See Disease Characteristics

Investigators

  • Investigator: Panayiotis Savvides, MD - Study Chair - Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Locations

  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

    Cleveland, Ohio 44106-5065 United States

  • MetroHealth Medical Center

    Cleveland, Ohio 44109 United States

Conditions related to this trial:

advertisement
V2012.311.925.327
Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.